Main Industry
Biotechnology
Main Product/Service
The 619 Protein Drug Platform is a specialized system for developing protein-based therapeutics, focusing on harnessing naturally sourced proteins with unique functions to create drug candidates with reduced or minimal side effects for applications in cancer, degenerative central nervous system diseases, and regenerative medicine.
Founded Year
1900
Unified Business No.
93555813
Status
Active
Number of Employees
5
Total Paid-in
Capital
2,100,000 (NT$)
Location of Company
Taiwan
, Yunlin County
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, MOE. Exit status refers to various situations, including emerging stock exchanges (e.g., potential exits), mergers and acquisitions (M&A), and IPOs. The overseas development countries are collected through information provided by startups themselves and the information filled in when registering for matchmaking events. Therefore, the information cannot be updated in real time. If you wish to make corrections, please email findit.tier@gmail.com. Thank you.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person. Please do not contact this platform for company inquiries.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Currently, most protein drug development relies on synthetic proteins, which are effective but often come with significant side effects. Our goal is to provide naturally sourced proteins as raw materials for protein drugs with low or even no side effects. Nexgen leverages a unique protein extraction and purification technology to obtain distinctive proteins from natural plants and animals, and, based on the diverse functions of these proteins, has expanded them into a protein drug candidate platform targeting cancer, degenerative central nervous system diseases, and regenerative medicine.
